Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| UMBF | Graves Greg M | Director | 09/01/2026 | Kauf | 139.60 | 573 | 79,991 | Form 4 |
| ULS | Scanlon Jennifer F. | President and CEO | 09/01/2026 | Verkauf | 74.43 | 2,005 | 149,225 | Form 4 |
| ULS | Scanlon Jennifer F. | President and CEO | 09/01/2026 | Verkauf | 73.52 | 10,495 | 771,575 | Form 4 |
| TOUR | Chen Anqiang | Financial Controller | 09/01/2026 | Optionsausübung | 0.003 | 149 | 0 | Form 4 |
| TRU | Ruebensaal Clayton F. | EVP, Chief Marketing & Comms | 09/01/2026 | Zuteilung | — | 5,976 | — | Form 4 |
| TRU | Skinner Todd C. | President, International | 09/01/2026 | Verkauf | 84.42 | 1,000 | 84,420 | Form 4 |
| TRU | Chaouki Steven M | President, US Markets | 09/01/2026 | Verkauf | 84.42 | 1,000 | 84,420 | Form 4 |
| TRU | Achanta Venkat | EVP, Chief Tech, Data & Analy. | 09/01/2026 | Zuteilung | — | 71,710 | — | Form 4 |
| TEM | Fukushima Ryan | CEO, Data | 09/01/2026 | Verkauf | 64.63 | 1,000 | 64,630 | Form 4 |
| TEM | Fukushima Ryan | CEO, Data | 09/01/2026 | Verkauf | 63.80 | 5,900 | 376,420 | Form 4 |
| TEM | Fukushima Ryan | CEO, Data | 09/01/2026 | Verkauf | 62.64 | 10,900 | 682,776 | Form 4 |
| TEM | Fukushima Ryan | CEO, Data | 09/01/2026 | Verkauf | 62.12 | 13,046 | 810,418 | Form 4 |
| TEM | Doudna Jennifer A | Director | 09/01/2026 | Verkauf | 65.55 | 676 | 44,312 | Form 4 |
| TEM | Epstein David R | Director | 09/01/2026 | Verkauf | 65.55 | 250 | 16,388 | Form 4 |
| TDOC | Nueno Carlos | President, International | 09/01/2026 | Optionsausübung | — | 8,717 | — | Form 4 |
| TDOC | Nueno Carlos | President, International | 09/01/2026 | Optionsausübung | — | 4,556 | — | Form 4 |
| TDOC | Rodrigues Fernando M. | President of BetterHelp | 09/01/2026 | Optionsausübung | — | 8,717 | — | Form 4 |
| TDOC | Rodrigues Fernando M. | President of BetterHelp | 09/01/2026 | Optionsausübung | — | 1,042 | — | Form 4 |
| TDOC | Rodrigues Fernando M. | President of BetterHelp | 09/01/2026 | Optionsausübung | — | 5,492 | — | Form 4 |
| TDOC | Bliss Kelly | President, U.S. Group Health | 09/01/2026 | Optionsausübung | — | 1,300 | — | Form 4 |
| TDOC | Bliss Kelly | President, U.S. Group Health | 09/01/2026 | Optionsausübung | — | 9,152 | — | Form 4 |
| TDOC | Bliss Kelly | President, U.S. Group Health | 09/01/2026 | Optionsausübung | — | 4,859 | — | Form 4 |
| TDOC | Catapano Joseph Ronald | Chief Accounting Officer | 09/01/2026 | Optionsausübung | — | 39 | — | Form 4 |
| TDOC | Catapano Joseph Ronald | Chief Accounting Officer | 09/01/2026 | Optionsausübung | — | 833 | — | Form 4 |
| TDOC | Vandervoort Adam C | CHIEF LEGAL OFFICER, SECRETARY | 09/01/2026 | Optionsausübung | — | 426 | — | Form 4 |
| TDOC | Vandervoort Adam C | CHIEF LEGAL OFFICER, SECRETARY | 09/01/2026 | Optionsausübung | — | 9,152 | — | Form 4 |
| TDOC | Vandervoort Adam C | CHIEF LEGAL OFFICER, SECRETARY | 09/01/2026 | Optionsausübung | — | 5,350 | — | Form 4 |
| TDOC | Divita Charles Iii | CHIEF EXECUTIVE OFFICER | 09/01/2026 | Optionsausübung | — | 1,966 | — | Form 4 |
| TDOC | Divita Charles Iii | CHIEF EXECUTIVE OFFICER | 09/01/2026 | Optionsausübung | — | 42,277 | — | Form 4 |
| TARS | Lin Elizabeth Yeu | Chief Medical Officer | 09/01/2026 | Verkauf | 73.86 | 4,601 | 339,830 | Form 4 |
| TRGP | Secrest Brent B. | See Remarks | 09/01/2026 | Zuteilung | — | 10,000 | — | Form 4 |
| TRGP | Chung Paul W | Director | 09/01/2026 | Verkauf | 297.00 | 816 | 242,352 | Form 4 |
| TRGP | Chung Paul W | Director | 09/01/2026 | Verkauf | 295.38 | 1,000 | 295,381 | Form 4 |
| TNGX | Crystal Adam | President, R&D | 09/01/2026 | Verkauf | 22.37 | 27,000 | 603,909 | Form 4 |
| TNGX | Crystal Adam | President, R&D | 09/01/2026 | Optionsausübung | 5.20 | 27,000 | 140,400 | Form 4 |
| TKR | Boldea Lucian | President and CEO | 09/01/2026 | Steuer-Abgabe | 119.78 | 3,333 | 399,227 | Form 4 |
| TKR | Boldea Lucian | President and CEO | 09/01/2026 | Zuteilung | — | 7,918 | — | Form 4 |
| TKR | Boldea Lucian | President and CEO | 09/01/2026 | Steuer-Abgabe | 119.78 | 12,750 | 1,527,195 | Form 4 |
| TKR | Boldea Lucian | President and CEO | 09/01/2026 | Zuteilung | — | 30,286 | — | Form 4 |
| TDC | Fisher Melissa B | Director | 09/01/2026 | Zuteilung | — | 344 | — | Form 4 |
| TDC | Fisher Melissa B | Director | 09/01/2026 | Zuteilung | — | 619 | — | Form 4 |
| TMUS | Almeida Andre | Chief Commercial Officer | 09/01/2026 | Steuer-Abgabe | 182.16 | 530 | 96,545 | Form 4 |
| SYM | Kane Charles | Director | 09/01/2026 | Verkauf | 39.00 | 2,000 | 78,000 | Form 4 |
| SYM | Kane Charles | Director | 09/01/2026 | J | — | 2,000 | — | Form 4 |
| STOK | Ticho Barry | CHIEF MEDICAL OFFICER | 09/01/2026 | Verkauf | 31.06 | 1,600 | 49,691 | Form 4 |
| STOK | Ticho Barry | CHIEF MEDICAL OFFICER | 09/01/2026 | Verkauf | 30.51 | 3,945 | 120,370 | Form 4 |
| SYRE | King-Jones Heidy | See Remarks | 09/01/2026 | Verkauf | 89.38 | 400 | 35,752 | Form 4 |
| SYRE | King-Jones Heidy | See Remarks | 09/01/2026 | Verkauf | 88.17 | 6,206 | 547,183 | Form 4 |
| SYRE | King-Jones Heidy | See Remarks | 09/01/2026 | Verkauf | 87.20 | 16,548 | 1,442,986 | Form 4 |
| SYRE | King-Jones Heidy | See Remarks | 09/01/2026 | Verkauf | 86.40 | 4,845 | 418,608 | Form 4 |
| SYRE | King-Jones Heidy | See Remarks | 09/01/2026 | Optionsausübung | 14.50 | 27,999 | 405,986 | Form 4 |
| SYRE | Burrows Scott L | Chief Financial Officer | 09/01/2026 | Verkauf | 89.04 | 200 | 17,808 | Form 4 |
| SYRE | Burrows Scott L | Chief Financial Officer | 09/01/2026 | Verkauf | 88.03 | 2,016 | 177,468 | Form 4 |
| SYRE | Burrows Scott L | Chief Financial Officer | 09/01/2026 | Verkauf | 87.11 | 4,384 | 381,890 | Form 4 |
| SYRE | Burrows Scott L | Chief Financial Officer | 09/01/2026 | Verkauf | 86.25 | 900 | 77,625 | Form 4 |
| SYRE | Burrows Scott L | Chief Financial Officer | 09/01/2026 | Optionsausübung | 14.50 | 7,500 | 108,750 | Form 4 |
| SYRE | Turtle Cameron | Chief Executive Officer | 09/01/2026 | Verkauf | 89.07 | 400 | 35,628 | Form 4 |
| SYRE | Turtle Cameron | Chief Executive Officer | 09/01/2026 | Verkauf | 88.06 | 3,700 | 325,822 | Form 4 |
| SYRE | Turtle Cameron | Chief Executive Officer | 09/01/2026 | Verkauf | 87.15 | 8,400 | 732,060 | Form 4 |
| SYRE | Turtle Cameron | Chief Executive Officer | 09/01/2026 | Verkauf | 86.36 | 2,500 | 215,900 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).